Study repli­cates piv­otal tri­al re­sults us­ing 're­al world ev­i­dence'

A study pub­lished in JA­MA In­ter­nal Med­i­cine on Mon­day was able to repli­cate the re­sults of a large ran­dom­ized con­trolled clin­i­cal tri­al for the blood pres­sure drug telmis­ar­tan us­ing so-called re­al world ev­i­dence gath­ered from in­sur­ance claims da­ta.

The goal of the study, which was con­duct­ed by re­searchers at Har­vard Med­ical School, was to in­ves­ti­gate whether health care data­bas­es can be used to con­firm find­ings from clin­i­cal tri­als con­duct­ed to sup­port ad­di­tion­al in­di­ca­tions for al­ready ap­proved drugs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.